Kaplan–Meier survival curves revealed that patients in the GS 6–7 group with T1 prostate cancer and PSA ≤ 4 ng/mL had better prognoses than did those in the PSA 4.1–10 ng/mL subgroup (Fig. 1A). This evidence concerns the gene KLK3 and Familial prostate cancer.